QR رمز

Fulvestrant in hormone-positive advanced breast cancer: Real-world outcome

Background: Fulvestrant has been shown to improve survival in hormone-positive, HER2-negative advanced breast cancer (ABC). There is no study on fulvestrant from India. Objectives: This study was done to assess the prognostic factors and outcome of patients with ABC treated with fulvestrant. Materia...

وصف كامل

محفوظ في:
المؤلفون الرئيسيون: Indhuja Muthiah Vaikundaraja, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Arun Kumar Rajan, Gangothri Selvarajan, Siva Sree Kesana, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar
التنسيق: Artigo
اللغة:Inglês
منشور في: Wolters Kluwer Medknow Publications 2020-01-01
سلاسل:Cancer Research, Statistics, and Treatment
الموضوعات:
advanced breast cancer
fulvestrant
hormone positive
الوصول للمادة أونلاين:http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=2;spage=275;epage=280;aulast=Vaikundaraja
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة